Lower cardiac tropinin T and I results in heparin-plasma than in serum

Clinical Chemistry

Volumn 46, Issue 9, 2000, Pages 1338-1344

  Stiegler, H ^a   Fischer, Y ^a   Vazquez Jimenez, J F ^a   Graf, J ^a   Filzmaier, K ^a   Fausten, B ^a   Janssens, U ^a   Gressner, A M ^a   Kunz, D ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; HEPARIN LYASE; TROPONIN I; TROPONIN T; ANTICOAGULANT AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LABORATORY TEST; MALE; PLASMA; PROTEIN BLOOD LEVEL; SERUM; ACUTE DISEASE; BLOOD; CORONARY ARTERY DISEASE; LABORATORY DIAGNOSIS; MIDDLE AGED; REGRESSION ANALYSIS;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CORONARY DISEASE; FALSE POSITIVE REACTIONS; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; TROPONIN I; TROPONIN T;

EID: 0033624182     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/46.9.1338     Document Type: Article

References (16)

1. False increase of troponin I attributable to incomplete separation of serum
2. National Academy of Clinical Biochemistry Standards of Laboratory Practice: Recommendations for the use of cardiac markers in coronary artery disease
3. Strategies for cardiac marker measurement
4. Troponin T and I assays show decreased concentrations in heparin plasma compared with serum: Lower recoveries in early than in late phase of myocardial injury
5. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management
6. Use of heparinase to eliminate heparin inhibition in routine coagulation assays
7. A new biometrical procedure for testing the equality of measurements from two different analytical methods
8. Statistical methods for assessing the agreement between two methods of clinical measurement
9. Method comparison - A different approach
10. Clinical and analytical standardization issues confronting cardiac troponin I
11. False increase of cardiac troponin I with heterophilic antibodies
12. Needless treatment for presumed malignancy
13. Therapeutic efficiency of trirofiban in acute coronary syndromes
14. Coupling of calcium to the interaction of troponin I with troponin C from cardiac muscle
15. Heparin: Mechanisms of action, pharmacokinetics, dosing, considerations, monitoring, efficacy and safety
16. Biochemical factors influencing measurement of cardiac troponin I in serum